[{"indications": "Indications\u00a0treatment of chronic hyperuricaemia\r\nin gout (but see also NICE guidance)", "name": "FEBUXOSTAT", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "10 Musculoskeletal and joint diseases", "10.1 Drugs used in rheumatic diseases and gout", "10.1.4 Gout and cytotoxic-induced hyperuricaemia", "Long-term control of gout"], "cautions": "Cautions\u00a0administer prophylactic NSAID (not aspirin or salicylates) or colchicine for at least 6\r\nmonths after starting febuxostat to avoid precipitating an acute attack; transplant recipients; monitor liver function tests before and periodically during treatment\r\nas indicated; thyroid disorders; interactions: Appendix 1 (febuxostat)", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances, abnormal liver\r\nfunction tests; headache; rash; less commonly taste\r\ndisturbances, increased appetite; hypertension, oedema, flushing;\r\ndizziness, paraesthesia, drowsiness; influenza-like symptoms; haematuria,\r\nnephrolithiasis, increased urinary frequency, decreased libido; myalgia;\r\ndermatitis, pruritus, urticaria; rarely thirst, palpitation, asthenia, nervousness, insomnia, and renal impairment", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/204954.htm", "doses": ["adult over 18 years, 80\u00a0mg\r\nonce daily, if after 2\u20134 weeks serum uric acid greater than 6\u00a0mg/100\u00a0mL,\r\nincrease to 120\u00a0mg once daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014limited information available"}]